Abstract 607: Genomic analyses and novel models validate CDK4 as a therapeutic target in imatinib-resistant dermatofibrosarcoma protuberans

Adrián Mariño‐Enríquez, Jonathan A. Fletcher, Ewa Sicińska et al.|Cancer Research|2015

Cited by 0